PURPOSE: The recent development in radiosynthesis of the (11)C-carbamate function increases the potential of [(11)C]GR103545, which for the last decade has been regarded as promising for imaging the kappa-opioid receptor (kappa-OR) with PET. In the present study, [(11)C]GR103545 was evaluated in awake rhesus macaques. Separate investigations were performed to clarify the OR subtype selectivity of this compound. METHODS: Regional brain uptake kinetics of [(11)C]GR103545 was studied 0-120 min after injection. The binding affinity and opioid subtype selectivity of [(11)C]GR103545 was determined in cells transfected with cloned human opioid receptors. RESULTS: In vitro binding assays demonstrated a high affinity of GR103545 for kappa-OR (K(i) = 0.02 +/- 0.01 nM) with excellent selectivity over mu-OR (6 x 10(2)-fold) and) delta-OR (2 x 10(4)-fold). PET imaging revealed a volume of distribution (V(T)) pattern consistent with the known distribution of kappa-OR, with striatum = temporal cortex > cingulate cortex > frontal cortex > parietal cortex > thalamus > cerebellum. CONCLUSION: [(11)C]GR103545 is selective for kappa-OR and holds promise for use to selectively depict and quantify this receptor in humans by means of PET.
PURPOSE: The recent development in radiosynthesis of the (11)C-carbamate function increases the potential of [(11)C]GR103545, which for the last decade has been regarded as promising for imaging the kappa-opioid receptor (kappa-OR) with PET. In the present study, [(11)C]GR103545 was evaluated in awake rhesus macaques. Separate investigations were performed to clarify the OR subtype selectivity of this compound. METHODS: Regional brain uptake kinetics of [(11)C]GR103545 was studied 0-120 min after injection. The binding affinity and opioid subtype selectivity of [(11)C]GR103545 was determined in cells transfected with cloned human opioid receptors. RESULTS: In vitro binding assays demonstrated a high affinity of GR103545 for kappa-OR (K(i) = 0.02 +/- 0.01 nM) with excellent selectivity over mu-OR (6 x 10(2)-fold) and) delta-OR (2 x 10(4)-fold). PET imaging revealed a volume of distribution (V(T)) pattern consistent with the known distribution of kappa-OR, with striatum = temporal cortex > cingulate cortex > frontal cortex > parietal cortex > thalamus > cerebellum. CONCLUSION: [(11)C]GR103545 is selective for kappa-OR and holds promise for use to selectively depict and quantify this receptor in humans by means of PET.
Authors: H J Wester; F Willoch; T R Tölle; F Munz; M Herz; I Oye; J Schadrack; M Schwaiger; P Bartenstein Journal: J Nucl Med Date: 2000-07 Impact factor: 10.057
Authors: Peter S Talbot; Raj Narendran; Eduardo R Butelman; Yiyun Huang; Kim Ngo; Mark Slifstein; Diana Martinez; Marc Laruelle; Dah-Ren Hwang Journal: J Nucl Med Date: 2005-03 Impact factor: 10.057
Authors: F Simonin; K Befort; C Gavériaux-Ruff; H Matthes; V Nappey; B Lannes; G Micheletti; B Kieffer Journal: Mol Pharmacol Date: 1994-12 Impact factor: 4.436
Authors: F Simonin; C Gavériaux-Ruff; K Befort; H Matthes; B Lannes; G Micheletti; M G Mattéi; G Charron; B Bloch; B Kieffer Journal: Proc Natl Acad Sci U S A Date: 1995-07-18 Impact factor: 11.205
Authors: Ming-Qiang Zheng; Su Jin Kim; Daniel Holden; Shu-fei Lin; Anne Need; Karen Rash; Vanessa Barth; Charles Mitch; Antonio Navarro; Michael Kapinos; Kathleen Maloney; Jim Ropchan; Richard E Carson; Yiyun Huang Journal: J Nucl Med Date: 2014-05-22 Impact factor: 10.057
Authors: Mika Naganawa; Leslie K Jacobsen; Ming-Qiang Zheng; Shu-Fei Lin; Anindita Banerjee; Wonkyung Byon; David Weinzimmer; Giampaolo Tomasi; Nabeel Nabulsi; Sarah Grimwood; Lori L Badura; Richard E Carson; Timothy J McCarthy; Yiyun Huang Journal: Neuroimage Date: 2014-05-17 Impact factor: 6.556
Authors: Michael S Placzek; Genevieve C Van de Bittner; Hsiao-Ying Wey; Scott E Lukas; Jacob M Hooker Journal: Neuropsychopharmacology Date: 2015-06-10 Impact factor: 7.853
Authors: Justin S Baba; Christopher J Endres; Catherine A Foss; Sridhar Nimmagadda; Hyeyun Jung; James S Goddard; Seungjoon Lee; John McKisson; Mark F Smith; Alexander V Stolin; Andrew G Weisenberger; Martin G Pomper Journal: J Nucl Med Date: 2013-03-27 Impact factor: 10.057
Authors: Jeffrey M Miller; Francesca Zanderigo; Priya D Purushothaman; Christine DeLorenzo; Harry Rubin-Falcone; R Todd Ogden; John Keilp; Maria A Oquendo; Nabeel Nabulsi; Yiyun H Huang; Ramin V Parsey; Richard E Carson; J John Mann Journal: Synapse Date: 2018-07-17 Impact factor: 2.562